Mammalian live/dead viability and cytotoxicity staining
Materials Required
Principle
Live/dead viability and cytotoxicity staining assays are based on the simultaneous detection of intracellular esterase activity in metabolically active (viable) cells and membrane integrity loss in non-viable cells. In commonly used dual-staining approaches, membrane-permeant fluorogenic substrates are converted by intracellular esterases into fluorescent products in live cells, while impermeant DNA-binding dyes selectively enter cells with compromised plasma membranes and label nucleic acids in dead or dying cells, enabling discrimination between viable and non-viable populations by fluorescence microscopy or flow cytometry[1].
MCE has not independently verified the accuracy of these methods. They are for reference only.
Experimental Materials
• Fluorescent viability probes typically include esterase substrates for live-cell labeling and membrane-impermeant nucleic acid stains for dead-cell detection, which together enable ratiometric or dual-channel assessment of cytotoxicity and viability in mammalian cell populations[1].
• Fluorescence microscopy or flow cytometry instrumentation is used to detect and quantify differential fluorescence signals from live and dead cell populations, allowing qualitative imaging or quantitative cytotoxicity assessment at single-cell resolution[1].
Experimental Procedure
• Staining reagents are prepared according to manufacturer- or literature-reported handling principles for light-sensitive fluorescent probes to preserve signal integrity[1].
• Cells are incubated with a combination of viability and dead-cell fluorescent probes, allowing simultaneous labeling of metabolically active cells and cells with compromised membrane integrity[1].
• After incubation, samples are directly analyzed using fluorescence microscopy or flow cytometry to detect spatial or population-level differences in fluorescence signals corresponding to live and dead cells[1].
• Viability is determined by quantifying the proportion of cells exhibiting esterase-dependent fluorescence relative to total cell number, while cytotoxicity is assessed by measuring the fraction of cells positive for membrane-impermeant nuclear staining[1].
• Appropriate controls include untreated cells as viability-positive controls and chemically or physically damaged cells as death-positive controls, enabling validation of assay sensitivity and dynamic range[1].
Troubleshooting
Problem: Weak fluorescence signal in viable cells
Possible Cause: Reduced intracellular esterase activity due to compromised cell health or suboptimal assay conditionsLiterature-supported Solution: Ensure that cells are in log-phase growth and handle under physiological conditions prior to staining to preserve metabolic activity required for probe conversion[1].
Problem: High background staining in control (viable) samples
Possible Cause: Loss of membrane integrity due to overhandling or suboptimal cell conditionLiterature-supported Solution: Minimize mechanical stress during washing and handling steps to preserve plasma membrane integrity and reduce nonspecific uptake of impermeant dyes[1].